Atia Vision, Inc., a Campbell, Calif.-based company committed to improving patient outcomes through the development of a modular presbyopia-correcting accommodating intraocular lens, closed its second tranche of a Series D $20M financing.
The round was led by Cormorant Asset Management, with participation from the Capital Partnership (TCP), AMED Ventures and Shangbay Capital.
The company intends to use the funds to continue early clinical experience treating cataract patients and support expansion of its facility.
Led by Mariam Maghribi, President and CEO, Atia Vision is advancing modular intraocular lens, which features an accommodating base responsive to the ciliary muscles, simulating the natural mechanism of the eye and fixed lens element that allows for subsequent refractive correction. It is still subject to regulatory approval and is not commercially available. The company is formed by Shifamed LLC, a Silicon Valley based medical innovation hub.